Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ocular Therapeutix Inc. buy Citigroup Inc.

Ocular Therapeutix Inc.
Start price
€5.89
17.02.26 / 50%
Target price
-
17.02.27
Performance (%)
49.30%
Price
€8.80
13.08.26
Summary
This prediction is currently active. With a performance of 49.30% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 17.02.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ocular Therapeutix Inc. 15.789% 15.789%
iShares Core DAX® 0.881% 5.632%
iShares Nasdaq 100 2.390% 1.571%
iShares Nikkei 225® 4.269% 2.521%
iShares S&P 500 1.171% 2.545%

Comments by Citigroup_Inc_ for this prediction

In the thread Ocular Therapeutix Inc. diskutieren

Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for OCUL provided by MarketBeat

Citigroup Inc. 
0
Report Share
17.02.26 Buy 49.30%

Stopped prediction by Citigroup_Inc_ for Ocular Therapeutix Inc.

buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€10.43
01.10.25
-
01.10.26
-15.59%
13.08.26

Citigroup Inc. 
01.10.25 50%